|
|
Volumn 330, Issue 7496, 2005, Pages 904-905
|
|
Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HISTAMINE H1 RECEPTOR ANTAGONIST;
LORATADINE;
NON PRESCRIPTION DRUG;
COST BENEFIT ANALYSIS;
DRUG COST;
ECONOMICS;
HUMAN;
NOTE;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUGS, NON-PRESCRIPTION;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
LORATADINE;
|
|
EID: 17244376696
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.330.7496.904-c Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
